๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Aflibercept - Medicines in Ireland

17 authorised products containing Aflibercept, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 17 authorised medicines
MedicineActive substanceLicence holderStatus
Afqlir
EU/1/24/1867/001
Aflibercept Sandoz GmbH โ€”
Afqlir
EU/1/24/1867/002
Aflibercept Sandoz GmbH โ€”
Ahzantive 40 mg/ml Solution for injection
EU/1/24/1888/001
Aflibercept Formycon AG โ€”
Baiama 40 mg/mL solution for injection in a vial
EU/1/24/1887/001
Aflibercept Formycon AG โ€”
Eylea 114.3 mg/ml solution for injection
EU/1/12/797/003
Aflibercept Bayer AG โ€”
Eylea 114.3 mg/ml solution for injection in pre-filled syringe
EU/1/12/797/004
Aflibercept Bayer AG โ€”
Eylea 40 mg/mL solution for injection
EU/1/12/797/001-002
Aflibercept Bayer AG โ€”
Eyluxvi 40mg/ml Solution for injection in vial
EU/1/25/1972/001
Aflibercept Biolitec Pharma Limited โ€”
MYNZEPLI 40 mg/mL solution for injection in a vial
EU/1/25/1964/001
Aflibercept Advanz Pharma Limited โ€”
MYNZEPLI 40 mg/mL solution for injection in pre-filled syringe
EU/1/25/1964/002
Aflibercept Advanz Pharma Limited โ€”
Opuviz 40 mg/mL solution for injection in a vial
EU/1/24/1865/001-002
Aflibercept Samsung Bioepis NL B.V. โ€”
PAVBLU 40 mg/mL solution for injection in a vial
EU/1/25/1909/002
Aflibercept Amgen Technology (Ireland) Unlimited Company โ€”
PAVBLU 40 mg/mL solution for injection in pre-filled syringe
EU/1/25/1909/001
Aflibercept Amgen Technology (Ireland) Unlimited Company โ€”
Vgenfli 40 mg/mL solution for injection in a vial
EU/1/25/1961/002
Aflibercept Zaklady Farmaceutyczne Polpharma S.A. โ€”
Vgenfli 40 mg/mL solution for injection in pre-filled syringe
EU/1/25/1961/001
Aflibercept Zaklady Farmaceutyczne Polpharma S.A. โ€”
Yesafili 40 mg/mL solution for injection in pre-filled syringe.
EU/1/23/1751/001-002
Aflibercept Biosimilar Collaborations Ireland Limited โ€”
ZALTRAP 25 mg/ml concentrate for solution for infusion
EU/1/12/814/001-003
Aflibercept Sanofi Winthrop Industrie โ€”
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.